Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).

Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).

Bibliographic Details
Main Authors:	Deighton, C, George, E, Kiely, P, Ledingham, J, Luqmani, R, Scott, D
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Comment on: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years): reply
by: Luqmani, R, et al.
Published: (2009)

British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).
by: Luqmani, R, et al.
Published: (2006)

British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).
by: Luqmani, R, et al.
Published: (2009)

The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis
by: S. Parisi, et al.
Published: (2019-09-01)

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
by: Bukhari, M, et al.
Published: (2011)

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
by: Tillett, W, et al.
Published: (2020)

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
by: Ding, T, et al.
Published: (2010)

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
by: Deighton, C, et al.
Published: (2010)

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
by: Deighton, C, et al.
Published: (2010)

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
by: Furst, D, et al.
Published: (2000)

Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
by: Tucker, L, et al.
Published: (2022)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995)

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy (vol 49, pg 1197, 2010)
by: Deighton, C, et al.
Published: (2010)

Developing multidisciplinary guidelines for the management of early rheumatoid arthritis.
by: Hennell, S, et al.
Published: (2008)

Egyptian guidelines for the treatment of Rheumatoid Arthritis — 2022 update
by: Yasser El Miedany, et al.
Published: (2022-10-01)

Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines
by: Mohammed A. Omair, et al.
Published: (2022-11-01)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
by: Feldmann, M
Published: (1996)

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope
by: Mercer, L, et al.
Published: (2024)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
by: Davis, D, et al.
Published: (1997)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)

Brazilian society of rheumatology methodological guide for the development of evidence-based clinical guidelines in rheumatology
by: Ana Karla Guedes de Melo, et al.
Published: (2023-03-01)

Rheumatologic service and prevalence of rheumatoid arthritis in Karachaevo-Cherkessk republik
by: A B Pavlova
Published: (2009-10-01)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
by: Maini, R, et al.
Published: (1999)

Hong Kong Guangdong Rheumatology Meeting <subtitle>ACR and EULAR Management Guidelines for Rheumatoid Arthritis: Consistency and Controversy</subtitle>
by: Ho SO
Published: (2023-11-01)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)

Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors
by: Zoltan Szekanecz, et al.
Published: (2022-11-01)

Treatment of vasculitis in rheumatoid arthritis.
by: Luqmani, R, et al.
Published: (1994)

BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
by: Keat, A, et al.
Published: (2005)

British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.
by: Harris, M, et al.
Published: (2011)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
by: Taylor, P, et al.
Published: (1999)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
by: Buchan, G, et al.
Published: (1988)

Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology
by: E. L. Nasonov, et al.
Published: (2018-06-01)

Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology
by: E. L. Nasonov, et al.
Published: (2022-12-01)

National Rheumatology Summit. Place of adalimumab in current pharmacotherapy strategy for rheumatoid arthritis
by: Article Editorial
Published: (2015-09-01)

Rheumoorthopedy of juvenile rheumatoid arthritis and juve nile chronic arthritis in clinical practice of the Institute of Rheumatology of RAMS
by: V P Pavlov
Published: (2005-08-01)

EMEUNET and the Section of Young Rheumatologists of the Polish Society of Rheumatology activities – an update
by: Magdalena Włoch-Targońska, et al.
Published: (2022-02-01)

Six-Month Follow-Up of Periodontal Condition in Rheumatoid Arthritis and Ankylosing Spondylitis Arthritis Patients Undergoing Anti-Tumour Necrosis Factor-α Therapy
by: Ildikó Tar, et al.
Published: (2024-01-01)

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
by: Mukhtyar, C, et al.
Published: (2005)

Update to “guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force”
by: Anna Carolina Faria Moreira Gomes Tavares, et al.
Published: (2022-07-01)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
by: Feldmann, M, et al.
Published: (1994)